• Users Online: 412
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2020  |  Volume : 6  |  Issue : 2  |  Page : 111-115

Myocarditis in Coronavirus disease 2019: Not an equivalent to troponinitis

Department of Cardiology, AIIMS, New Delhi, India

Correspondence Address:
Dr. Saikrishna Reddy
Department of Cardiology, AIIMS, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jpcs.jpcs_56_20

Rights and Permissions

Coronavirus disease 2019 (COVID-19) has affected around 5 million people and is on raising trend. It has overwhelmed the health-care systems of all specialties including cardiology. Cardiac involvement has been seen based on the early reports from China showing elevation of troponin and especially in the critical cases varying form 7%–28%. Speculations were made about the possibilities of myocarditis based on those reports. This short review attempted to methodologically look at available clinical evidence on the true incidence of myocarditis in COVID-19. The data suggest that troponin elevation is not equal to either ischemic heart disease or myocarditis and is some form of nonischemic myocardial injury and a marker of higher morbidity. It is related to the cytokine storm, but more information is needed on its pathogenesis.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded170    
    Comments [Add]    

Recommend this journal